Trial
NCT05539365
Dendritic Cell-Based Treatment Plus Immunotherapy for the Treatment of Metastatic or Unresectable Triple Negative Breast Cancer
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Roswell Park Cancer Institute
Collaborators
—
Condition
Anatomic Stage III Breast Cancer AJCC v8
Intervention
Alpha-type-1 Polarized Dendritic Cells
Why stopped
Study never activated.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-01-29